Literature DB >> 6624881

Release of phospholipase A2 activity from rabbit peritoneal neutrophils by f-Met-Leu-Phe.

C Lanni, E L Becker.   

Abstract

Rabbit peritoneal neutrophils secrete phospholipase A2 activity in response to f-Met-Leu-Phe (FMLP). The secretion of phospholipase A2, like that of the known granule enzymes, requires cytochalasin B and is enhanced by extracellular Ca2+, and the time course of the release is rapid, being completed in less than a minute. The concentration dependence of the secretion of the phospholipase is the same as that of the known granule enzymes up to 10(-9) M FMLP. At this concentration, the release of the known granule enzymes reaches a maximum, but that of phospholipase A2 does not until 10(-8) M FMLP. The amount of enzyme activity released plus the amount of enzyme activity remaining in the pellet is distinctly greater than the total enzyme activity extractable from the cell before release. The phospholipase secreted is active in the neutral to alkaline range, requires Ca2+, is inhibited by low levels of detergent, and is of A2 specificity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6624881      PMCID: PMC1916300     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  14 in total

1.  Phospholipase A in pulmonary secretions of patients with alveolar proteinosis.

Authors:  S Sahu; W S Lynn
Journal:  Biochim Biophys Acta       Date:  1977-05-25

2.  Phospholipase A activity associated with membranes of human polymorphonuclear leucocytes.

Authors:  R Franson; J Weiss; L Martin; J K Spitznagel; P Elsbach
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

3.  Isolation and characterization of a phospholipase A2 from an inflammatory exudate.

Authors:  R Franson; R Dobrow; J Weiss; P Elsbach; W B Weglicki
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

4.  The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis, and adherence to nonphagocytosable surfaces.

Authors:  P M Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

5.  Phospholipase A2 activity in the plasma membrane of human polymorphonuclear leukocytes.

Authors:  M Victor; J Weiss; M S Klempner; P Elsbach
Journal:  FEBS Lett       Date:  1981-12-28       Impact factor: 4.124

6.  Phospholipase A2 contamination of cobra venom factor preparations. Biologic role in complement-dependent in vivo reactions and inactivation with p-bromophenacyl bromide.

Authors:  J O Shaw; M F Roberts; R J Ulevitch; P Henson; E A Dennis
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

7.  The appearance and significance of phospholipase A2 in lymph draining tuberculin reactions.

Authors:  P Vadas; J B Hay
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

8.  The efficacy of anti-inflammatory agents with respect to extracellular phospholipase A2 activity.

Authors:  P Vadas
Journal:  Life Sci       Date:  1982-01-11       Impact factor: 5.037

9.  Phospholipid metabolism by phagocytic cells. Phospholipases A2 associated with rabbit polymorphonuclear leukocyte granules.

Authors:  R Franson; P Patriarca; P Elsbach
Journal:  J Lipid Res       Date:  1974-07       Impact factor: 5.922

10.  The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.

Authors:  H J Showell; R J Freer; S H Zigmond; E Schiffmann; S Aswanikumar; B Corcoran; E L Becker
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  20 in total

1.  Modulation of leukotriene generation by pertussis toxin.

Authors:  T Hensler; M Raulf; F Megret; J E Alouf; W König
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

2.  Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytes.

Authors:  W Pruzanski; S Saito; E Stefanski; P Vadas
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

3.  Cationic factors affecting phospholipase activities from human lung.

Authors:  D A Yeats; Y S Bakhle
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

4.  The localization of phospholipase A2 in the secretory granule.

Authors:  S P Chock; E A Schmauder-Chock; E Cordella-Miele; L Miele; A B Mukherjee
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

5.  Cyclic AMP mimics, but does not mediate, interleukin-1- and tumour-necrosis-factor-stimulated phospholipase A2 secretion from rat renal mesangial cells.

Authors:  J Pfeilschifter; J Leighton; W Pignat; F Märki; K Vosbeck
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

6.  Phospholipid metabolism in human neutrophils activated by N-formyl-methionyl-leucyl-phenylalanine. Degranulation is not required for release of arachidonic acid: studies with neutrophils and neutrophil-derived cytoplasts.

Authors:  E M Wynkoop; M J Broekman; H M Korchak; A J Marcus; G Weissmann
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

7.  Differential inhibition of human secretory and cytosolic phospholipase A2.

Authors:  F Märki; W Breitenstein; E Beriger; R Bernasconi; G Caravatti; J E Francis; R Paioni; H U Wehrli; R Wiederkehr
Journal:  Agents Actions       Date:  1993-03

8.  Phospholipase A2 in human ascitic fluid. Purification, characterization and immunochemical detection.

Authors:  P T Kortesuo; T J Nevalainen
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

9.  Effect of N-formylated methionyl-phenylalanine (FMP) and methionyl-leucyl-phenylalanine (FMLP) on gut permeability. A model of local inflammatory process.

Authors:  K E Magnusson; C Dahlgren; A Sjölander
Journal:  Inflammation       Date:  1985-12       Impact factor: 4.092

10.  Characterization and pharmacological modulation of soluble phospholipase A2 generated during glycogen-induced rat peritonitis.

Authors:  L A Marshall; J Murphy; L Marinari; J Chang
Journal:  Agents Actions       Date:  1992-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.